Device type · JTN
Susceptibility Test Discs, Antimicrobial
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
JTN
Microbiology
Device class
Class II
FDA decisions since 2015
35
510(k), De Novo and PMA
Adverse event reports
4
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Susceptibility Test Discs, Antimicrobial
- Product code
- JTN
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.1620
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JTN
Latest FDA decisions
The 8 newest of 35 since 2015.
K262113 · Decided Aug 20, 2026 · 58 days after receipt
Device type: Susceptibility Test Discs, Antimicrobial (JTN) · Laboratory Medicine & Pathology
Thermo Fisher Scientific (Oxoid Ltd.)
K261781 · Decided Jul 24, 2026 · 56 days after receipt
Device type: Susceptibility Test Discs, Antimicrobial (JTN) · Laboratory Medicine & Pathology
- Gepotidacin GEP 10 µg510(k)
K261853 · Decided Jul 23, 2026 · 50 days after receipt
Device type: Susceptibility Test Discs, Antimicrobial (JTN) · Laboratory Medicine & Pathology
32 more FDA decisions with a free account
Reports received
4
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
4
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 3 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 1 | 0 | 0 | 0 |
| Apr 24 | 1 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 1 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 4 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 4 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Apparent Adverse Event4
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2887-2026 · Started Jun 8, 2026 · Posted by FDA Aug 5, 2026
Reason given: Due to incorrect cartridges include in affected products that there is the potential for false-susceptible or false-resistant susceptibility results and may lead to selection of an ineffective antimicrobial therapy, potentially resulting in delayed appropriate treatment, prolonged infection, or worsening clinical...
Cause as FDA categorized it: Under Investigation by firm
Z-1075-2025 · Started Dec 23, 2024 · Posted by FDA Feb 4, 2025
Reason given: Mislabeling; Levofloxacin Antimicrobial susceptibility disc packaging may contain Norfloxacin Antimicrobial Susceptibility discs.
Cause as FDA categorized it: Under Investigation by firm
Z-0621-2025 · Started Nov 6, 2024 · Posted by FDA Dec 5, 2024
Reason given: BD identified through potency testing as part of a stability test request to monitor Ampicillin AM-2 due to decrease in potency results of 65% at 18 months, may result in falsely resistant result for ampicillin susceptibility
Cause as FDA categorized it: Under Investigation by firm
44 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.